The Global Veterinary Diagnostics Market is undergoing a strong transformation as veterinary healthcare systems worldwide ...
Medical Device Network on MSN
FDA clears Cepheid’s Xpert GI panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...
The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...
As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...
Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...
An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...
* Transcription-mediated amplification (TMA) tests and commercially available reverse transcription polymerase chain reaction (RT-PCR) tests specifically designed to omit/adapt RNA ...
Introduction To investigate whether biochemical and haematological changes due to the patient’s host response (CoLab algorithm) in combination with a SARS-CoV-2 viability PCR (v-PCR) can be used to ...
PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results